Featured CME TOPIC: Prevention of Ovarian and Tubal Cancer

What is the problem?

In 2023, an estimated 19,710 people in the United States will be diagnosed with ovarian cancer. 90% of these cases are epithelial ovarian cancer, most high-grade serous ovarian cancers (HGSC) and begin in the fallopian tube. Ovarian cancer is more common in White women than in Black women, and it most commonly develops in older people (approx. 50% of people diagnosed with ovarian cancer are 63 or older). The 5-year relative survival rate for all types of ovarian, fallopian tube, and peritoneal cancers in the United States is 50%. Only about 20% of ovarian cancers are found at an early stage, but if they are diagnosed and treated before they spread outside the ovaries and tubes, the 5-year relative survival rate is 93%. Better ways to screen for ovarian cancer are being researched, but currently, there are no reliable screening tests. Healthcare professionals should know the current recommendations on risk factors and risk reduction for ovarian and fallopian tube cancers.

Learning Objectives

1. Recognize the risk of ovarian and fallopian tube cancer and factors that increase the baseline risk
2. ·Identify non-surgical methods of ovarian and fallopian tube cancer risk reduction
3. Describe surgical methods of ovarian and fallopian tube cancer risk reduction

CLICK HERE to download a PDF file featuring information gaps, potential needs, and references for this topic.

If your medical staff needs an update on ovarian and tubal cancer, consider contacting our office to book a speaker at 877-505-4777 or info@speakersnetwork.com.

REFERENCES

https://www.cancer.net/cancer-types/ovarian-fallopian-tube-and-peritoneal-cancer/statistics

https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/detection.html